US5656286A
(en)
*
|
1988-03-04 |
1997-08-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5474783A
(en)
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5103812A
(en)
*
|
1988-10-12 |
1992-04-14 |
Rochal Industries, Inc. |
Conformable bandage and coating material
|
US5246705A
(en)
*
|
1992-04-08 |
1993-09-21 |
Cygnus Therapeutic System |
Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
|
US5288827A
(en)
*
|
1993-02-17 |
1994-02-22 |
Ciba-Geigy Corporation |
Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives
|
GB9411530D0
(en)
*
|
1994-06-09 |
1994-08-03 |
Quayle Rachel A |
Use of polymers as film-forming barrier materials
|
DE69634277T2
(de)
*
|
1995-06-07 |
2006-01-05 |
Southern Biosystems, Inc., Birmingham |
Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US6730380B2
(en)
|
1996-02-20 |
2004-05-04 |
Safeskin Corp. |
Readily-donned elastomeric articles
|
US5948400A
(en)
*
|
1997-11-20 |
1999-09-07 |
Smith & Nephew Inc. |
Method of applying a pressure-sensitive adhesive wound dressing and water-based skin treatment composition
|
AU1800099A
(en)
*
|
1997-11-25 |
1999-06-15 |
Theratech, Inc. |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
BR0009332A
(pt)
|
1999-03-25 |
2006-06-06 |
3M Innovative Properties Co |
composição para aplicação a pele e métodos de preparar um polìmero que contém siloxano e de formular cosméticos e um medicamento tópico
|
US6471985B2
(en)
*
|
1999-06-04 |
2002-10-29 |
Bahman Guyuron |
Use of RTV silicone compositions for wound dressing
|
GB0003632D0
(en)
*
|
2000-02-16 |
2000-04-05 |
Univ Hong Kong Science & Techn |
Dimeric compounds
|
US6512072B1
(en)
|
2000-06-12 |
2003-01-28 |
Dow Corning Corporation |
Fast cure film forming formulation
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US6746667B2
(en)
|
2001-07-05 |
2004-06-08 |
Closure Medical Corporation |
Adhesive treatment for tinea pedis
|
US6585967B2
(en)
|
2001-07-05 |
2003-07-01 |
Closure Medical Corporation |
Adhesive treatment for tinea cruris
|
US6942875B2
(en)
*
|
2001-07-05 |
2005-09-13 |
Closure Medical Corporation |
Adhesive treatment for skin yeast infections
|
US6602496B2
(en)
|
2001-07-05 |
2003-08-05 |
Closure Medical Corporation |
Adhesive treatment for tinea corporis
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
JP4865330B2
(ja)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
経口ドラッグデリバリーシステム
|
US20040122382A1
(en)
*
|
2002-12-23 |
2004-06-24 |
Kimberly-Clark Worldwide, Inc. |
Elastomeric articles with beneficial coating on a surface
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
US20050031817A1
(en)
*
|
2003-08-07 |
2005-02-10 |
Littleton Kermit R. |
Readily donned, powder-free elastomeric article
|
US20050129937A1
(en)
*
|
2003-12-16 |
2005-06-16 |
Eastman Kodak Company |
Antimicrobial web for application to a surface
|
US7842749B2
(en)
*
|
2004-08-02 |
2010-11-30 |
Poly-Med, Inc. |
Tissue protecting spray-on copolymeric film composition
|
US20060030808A1
(en)
*
|
2004-08-09 |
2006-02-09 |
Aso Corporation |
Liquid bandage and tissue sealant
|
AU2005287175B2
(en)
|
2004-09-17 |
2011-12-01 |
Durect Corporation |
Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
|
EP1833918B1
(de)
|
2004-12-23 |
2011-09-28 |
Dow Corning Corporation |
Vernetzbare saccharid-siloxan-zusammensetzungen und daraus gebildete netzwerke, überzüge und artikel
|
JP4704764B2
(ja)
*
|
2005-02-03 |
2011-06-22 |
日東電工株式会社 |
爪貼付用粘着組成物および爪用貼付剤
|
US7318937B2
(en)
*
|
2005-03-18 |
2008-01-15 |
Closure Medical Corporation |
Liquid coating compositions
|
JP5122444B2
(ja)
|
2005-05-23 |
2013-01-16 |
ダウ・コーニング・コーポレイション |
サッカリド−シロキサンコポリマーを含むパーソナルケア組成物
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
CA2619886C
(en)
*
|
2005-08-17 |
2016-01-19 |
Ann Beal Salamone |
Conformable solvent-based bandage and coating material
|
AU2006321689B2
(en)
*
|
2005-12-07 |
2011-08-04 |
Rochal Technologies Llc |
Conformable bandage and coating material
|
KR101460980B1
(ko)
|
2006-05-23 |
2014-11-13 |
다우 코닝 코포레이션 |
활성제를 전달하기 위한 신규한 실리콘막 형성제
|
MX2009009557A
(es)
*
|
2007-03-08 |
2010-08-10 |
Crescendo Therapeutics Llc |
Formulaciones de aposito para prevenir o reducir la cicatrizacion.
|
US8173146B2
(en)
*
|
2007-04-23 |
2012-05-08 |
Safen'Simple LLC |
Stoma wipe and adhesive remover and method
|
US20080302827A1
(en)
*
|
2007-06-06 |
2008-12-11 |
Gerrish Donald L |
Spray dispenser
|
AU2008347158B8
(en)
|
2007-12-06 |
2013-08-22 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US8828358B2
(en)
*
|
2008-03-11 |
2014-09-09 |
Materials Modifications, Inc. |
In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
|
US8852558B2
(en)
*
|
2008-03-11 |
2014-10-07 |
Materials Modification, Inc. |
In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
|
CN102316894A
(zh)
|
2008-06-20 |
2012-01-11 |
惠氏有限责任公司 |
来自β-溶血性链球菌菌株的ORF1358的组合物和使用方法
|
US8003132B2
(en)
|
2008-06-30 |
2011-08-23 |
Johnson & Johnson Consumer Companies, Inc. |
Compositions comprising an ultraviolet radiation-absorbing polymer
|
CA2733642A1
(en)
|
2008-08-14 |
2010-02-18 |
Cephalon Australia Pty Ltd |
Anti-il-12/il-23 antibodies
|
DE102008048338A1
(de)
|
2008-09-22 |
2010-03-25 |
Beiersdorf Ag |
Wundversorgungszubereitung mit verminderten Hautirritationen
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
DE102008060904A1
(de)
*
|
2008-12-09 |
2010-06-10 |
Beiersdorf Ag |
Wasserlösliche Wirkstoffe in Sprühpflaster
|
US8957277B2
(en)
|
2009-04-27 |
2015-02-17 |
Avery Dennison Corporation |
Disruptable adhesive layer for fluid activated debonding
|
PL2424948T3
(pl)
|
2009-04-27 |
2017-08-31 |
Avery Dennison Corporation |
Rozłączalny klej mający wielowarstwowe podłoże
|
US8828425B2
(en)
*
|
2010-02-02 |
2014-09-09 |
Poly-Med, Inc. |
In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
|
US8475774B2
(en)
|
2010-02-08 |
2013-07-02 |
Johnson & Johnson Consumer Companies, Inc. |
Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer
|
WO2012027073A1
(en)
|
2010-08-23 |
2012-03-01 |
Dow Corning Corporation |
Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes
|
JP5754665B2
(ja)
*
|
2010-10-22 |
2015-07-29 |
アルケア株式会社 |
皮膚の痛み緩和用皮膜形成組成物
|
EP2741788A4
(de)
|
2011-08-14 |
2015-03-25 |
Materials Modification Inc |
Verfahren und zusammensetzung zur in-situ-bildung einer künstlichen sperre zur bekämpfung von blutverlust
|
EP2760951A1
(de)
|
2011-09-30 |
2014-08-06 |
3M Innovative Properties Company |
Konforme beschichtung und zusammensetzung
|
US8263720B1
(en)
*
|
2011-10-05 |
2012-09-11 |
Rochal Industries, Llp |
Sacrificial adhesive coatings
|
ES2568754T3
(es)
|
2011-10-31 |
2016-05-04 |
Avery Dennison Corporation |
Capa de adhesivo afectable para la desunión activada de fluido
|
CN104870567B
(zh)
|
2012-10-22 |
2018-09-07 |
艾利丹尼森公司 |
分散在胶黏剂中的交联的微凝胶颗粒的杂化材料
|
WO2014064703A1
(en)
*
|
2012-10-28 |
2014-05-01 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
US8852648B2
(en)
|
2012-11-06 |
2014-10-07 |
Rochal Industries, Llp |
Delivery of biologically-active agents using volatile, hydrophobic solvents
|
US9072747B2
(en)
|
2013-03-10 |
2015-07-07 |
Peritech Pharma Ltd. |
Topical compositions and methods of treatment of anorectal disorders
|
TW201521769A
(zh)
|
2013-03-15 |
2015-06-16 |
Durect Corp |
具有流變改質劑以減少溶解變異性之組成物
|
US20140272129A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Apple Inc. |
Compliant permeable glue applicator
|
WO2015017044A1
(en)
*
|
2013-07-27 |
2015-02-05 |
Colby Lawrence A |
Systems and methods for enhancing the visibility of medical items
|
US8877882B1
(en)
|
2013-10-04 |
2014-11-04 |
Rochal Industries Llp |
Non-self-adherent coating materials
|
CN106661107B
(zh)
|
2013-12-24 |
2021-12-24 |
杨森制药公司 |
抗vista抗体及片段
|
US9962461B2
(en)
|
2014-03-10 |
2018-05-08 |
3M Innovative Properties Company |
Conformable coating composition
|
EP3240823A4
(de)
*
|
2014-12-30 |
2018-08-01 |
Momentive Performance Materials Inc. |
Siloxankoordinationspolymere
|
WO2016153760A1
(en)
|
2015-03-23 |
2016-09-29 |
Clariant Corporation |
A catalyst material for the oxidation and ammoxidation of propylene and isopropylene, processes for making and using same
|
WO2016164316A1
(en)
|
2015-04-06 |
2016-10-13 |
3M Innovative Properties Company |
Removable film forming gel compositions and methods for their application
|
DK3313882T3
(da)
|
2015-06-24 |
2020-05-11 |
Janssen Pharmaceutica Nv |
Anti-VISTA antistoffer og fragmenter
|
CA3014013A1
(en)
|
2016-02-12 |
2017-08-17 |
Janssen Pharmaceutica Nv |
Anti-vista (b7h5) antibodies
|
EA201892190A1
(ru)
|
2016-03-29 |
2019-04-30 |
Янссен Байотек, Инк. |
Лечение псориаза антителом к ил-12 и/или ил-23 с возрастанием интервала между введениями дозы
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CA3037961A1
(en)
|
2016-09-30 |
2018-04-05 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il23 specific antibody
|
WO2018071278A1
(en)
*
|
2016-10-13 |
2018-04-19 |
3M Innovative Properties Company |
Removable film-forming gel compositions featuring adhesion promoters
|
KR20190078648A
(ko)
|
2016-11-16 |
2019-07-04 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 건선을 치료하는 방법
|
DE102017100443A1
(de)
*
|
2017-01-11 |
2018-07-12 |
Madeleine Elixmann |
Flüssigpflaster, Auftragevorrichtung und deren Verwendung
|
JP2020506916A
(ja)
|
2017-01-30 |
2020-03-05 |
ヤンセン バイオテツク,インコーポレーテツド |
活動性乾癬性関節炎の治療のための抗tnf抗体、組成物、及び方法
|
CA3052578A1
(en)
|
2017-02-07 |
2018-08-16 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
MX2020009265A
(es)
|
2018-03-05 |
2020-10-01 |
Janssen Biotech Inc |
Metodos para tratar la enfermedad de crohn con un anticuerpo especifico anti-il23.
|
US20200025776A1
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody
|
AU2019346134C1
(en)
|
2018-09-24 |
2024-06-20 |
Janssen Biotech, Inc. |
Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody
|
AU2019383017A1
(en)
|
2018-11-20 |
2021-06-03 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
|
US20200197517A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
|
US20220153827A1
(en)
|
2019-01-15 |
2022-05-19 |
Janssen Biotech, Inc. |
Anti-TNF Antibody Compositions and Methods for the Treatment of Juvenile Idiopathic Arthritis
|
EA202192038A1
(ru)
|
2019-01-23 |
2021-10-05 |
Янссен Байотек, Инк. |
Композиции антител к фно для применения в способах лечения псориатического артрита
|
EP3938384A4
(de)
|
2019-03-14 |
2022-12-28 |
Janssen Biotech, Inc. |
Herstellungsverfahren zur herstellung von anti-il12/il23-antikörperzusammensetzungen
|
WO2020183270A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
CA3133388A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
EP3938390A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Herstellungsverfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
KR20210141583A
(ko)
|
2019-03-18 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il-12/il-23 항체를 사용한 소아 대상의 건선 치료 방법
|
CA3138241A1
(en)
|
2019-05-23 |
2020-11-26 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
AU2020288404A1
(en)
|
2019-06-03 |
2022-02-03 |
Janssen Biotech, Inc. |
Anti-TNF antibodies, compositions, and methods for the treatment of active Ankylosing Spondylitis
|
CN113939531A
(zh)
|
2019-06-03 |
2022-01-14 |
詹森生物科技公司 |
用于治疗银屑病关节炎的抗tnf抗体组合物和方法
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|
CN111450310A
(zh)
*
|
2020-03-03 |
2020-07-28 |
劳龙斯(上海)医药科技有限公司 |
一种新型液体伤口敷料及其制备方法
|
CN111714692B
(zh)
*
|
2020-07-07 |
2022-04-15 |
华熙生物科技股份有限公司 |
一种皮肤创面保护组合物及其制备方法
|
US20220298236A1
(en)
|
2021-03-12 |
2022-09-22 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
|
WO2022190034A1
(en)
|
2021-03-12 |
2022-09-15 |
Janssen Biotech, Inc. |
Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
|
AU2022306973A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
JP2024526315A
(ja)
|
2021-07-09 |
2024-07-17 |
ヤンセン バイオテツク,インコーポレーテツド |
抗tnf抗体組成物を製造するための製造方法
|
EP4367136A1
(de)
|
2021-07-09 |
2024-05-15 |
Janssen Biotech, Inc. |
Herstellungsverfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
EP4423126A1
(de)
|
2021-10-29 |
2024-09-04 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von morbus crohn mit anti-il23-spezifischem antikörper
|
CA3238377A1
(en)
|
2021-11-15 |
2023-05-19 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
US20230312703A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of Treating Psoriasis with IL-23 Specific Antibody
|
US20230374122A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for Evaluating and Treating Psoriatic Arthritis with IL23 Antibody
|
US20240199734A1
(en)
|
2022-11-22 |
2024-06-20 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|